Skip to main content
. 2011 Jun;164(3):396–406. doi: 10.1111/j.1365-2249.2011.04382.x

Fig. 1.

Fig. 1

Serum levels of CXCL9-11 and interleukin (IL)-17 in inflammatory bowel disease (IBD) patients. The sera were collected from 26 ulcerative colitis (UC) patients and 10 healthy subjects. The levels of CXCL9, CXCL10, CXCL11 and IL-17 were determined by enzyme-linked immunosorbent assay. The scatter dot-plots indicate levels of CXCL9 (a), CXCL10 (b), CXCL11 (c) and IL-17 (d) in the sera. Each dot represents a datum from one subject.